Photocure

    OverviewSuggest Edit

    Photocure, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products and related technical medical equipment. The Company offers Hexvix/Cysview for the detection and management of bladder cancer. It is also developing Visonac that has completed Phase IIb study for the treatment of moderate to severe acne; and Cevira, which has completed Phase IIb study for the treatment of human papilloma virus infection and precancerous lesions of the cervix.

    TypePublic
    Founded1997
    HQUllern, NO
    Websitephotocure.com

    Latest Updates

    Employees (est.) (Feb 2019)60

    Key People/Management at Photocure

    Erik Dahl

    Erik Dahl

    Chief Financial Officer and Interim CEO
    Inger Ferner Heglund

    Inger Ferner Heglund

    Vice President Research and Development
    Grete Hogstad

    Grete Hogstad

    Vice President Strategic Marketing
    Show more

    Photocure Office Locations

    Photocure has offices in Ullern and Princeton
    Ullern, NO (HQ)
    4 Hoffsveien
    Princeton, US
    104 Carnegie Center Dr #303
    Show all (2)

    Photocure Online and Social Media Presence

    Embed Graph

    Photocure News and Updates

    Photocure ASA: Results for the Fourth Quarter of 2019

    OSLO, Norway, Feb. 27, 2020 /PRNewswire/ -- Photocure ASA (OSE: PHO), today reported a revenue growth of 51% for the U.S. market in the fourth quarter of 2019, contributing to Hexvix/Cysview revenues of NOK 58.8 million (Q4 2018: NOK 46.3) and a recurring EBITDA of NOK 1.6 million (NOK...

    Photocure ASA: Results for the Third Quarter of 2019

    OSLO, Norway, Nov. 7, 2019 /PRNewswire/ -- Photocure ASA (OSE: PHO), today reported a revenue growth of 42% in local currency for the U.S. market in the third quarter of 2019, contributing to Hexvix/Cysview revenues of NOK 51.1 million (Q3 2018: NOK 43.5) and an EBITDA of NOK 8.3 million...

    Asieris and Photocure Enter into a License Agreement for World-Wide Development and Commercialization of Cevira®

    SHANGHAI and OSLO, Norway, July 2, 2019 /PRNewswire/ -- Asieris MediTech Co, Ltd (Asieris), a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases, and Photocure ASA (Photocure, PHO:...

    Photocure Frequently Asked Questions

    • When was Photocure founded?

      Photocure was founded in 1997.

    • Who are Photocure key executives?

      Photocure's key executives are Erik Dahl, Inger Ferner Heglund and Grete Hogstad.

    • How many employees does Photocure have?

      Photocure has 60 employees.

    • Who are Photocure competitors?

      Competitors of Photocure include TP Therapeutics, Sunshine Biopharma and Angelini.

    • Where is Photocure headquarters?

      Photocure headquarters is located at 4 Hoffsveien, Ullern.

    • Where are Photocure offices?

      Photocure has offices in Ullern and Princeton.

    • How many offices does Photocure have?

      Photocure has 2 offices.